1. Antoni MH. Psychosocial intervention effects on adaptation, disease course and biobehavioral processes in cancer. Brain Behav Immun 2013;30(Suppl):S88–S98.
2. Gil F, Costa G, Hilker I, Benito L. First anxiety, afterwards depression: psychological distress in cancer patients at diagnosis and after medical treatment. Stress Health 2012;28:362–367.
3. Linden W, Vodermaier A, Mackenzie R, Greig D. Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord 2012;141:343–351.
4. Perez MN, Traino KA, Bakula DM, Sharkey CM, Espeleta HC, Delozier AM, et al. Barriers to care in pediatric cancer: the role of illness uncertainty in relation to parent psychological distress. Psychooncology 2020;29:304–310.
5. Vander Haegen M, Etienne AM. Intolerance of uncertainty in parents of childhood cancer survivors: a clinical profile analysis. J Psychosoc Oncol 2018;36:717–733.
6. Sharpe L, Curran L, Butow P, Thewes B. Fear of cancer recurrence and death anxiety. Psychooncology 2018;27:2559–2565.
7. Antoni MH, Dhabhar FS. The impact of psychosocial stress and stress management on immune responses in patients with cancer. Cancer 2019;125:1417–1431.
11. Logie C, Gadalla TM. Meta-analysis of health and demographic correlates of stigma towards people living with HIV. AIDS Care 2009;21:742–753.
12. Basu S, Chwastiak LA, Bruce RD. Clinical management of depression and anxiety in HIV-infected adults. AIDS 2005;19:2057–2067.
13. Nanni MG, Caruso R, Mitchell AJ, Meggiolaro E, Grassi L. Depression in HIV infected patients: a review. Curr Psychiatry Rep 2015;17:530
14. Houck MM, Siegel JA. Illicit Drugs. In: Houck MM, Siegel JA, editor. Fundamentals of Forensic Science (Third Edition). San Diego: Academic Press, 2015, p. 315–352.
15. Vollenweider FX, Kometer M. The neurobiology of psychedelic drugs: implications for the treatment of mood disorders. Nat Rev Neurosci 2010;11:642–651.
19. de Veen BT, Schellekens AF, Verheij MM, Homberg JR. Psilocybin for treating substance use disorders? Expert Rev Neurother 2017;17:203–212.
20. Grassi L, Caruso R, Hammelef K, Nanni MG, Riba M. Efficacy and safety of pharmacotherapy in cancer-related psychiatric disorders across the trajectory of cancer care: a review. Int Rev Psychiatry 2014;26:44–62.
21. Heissel A, Zech P, Rapp MA, Schuch FB, Lawrence JB, Kangas M, et al. Effects of exercise on depression and anxiety in persons living with HIV: a meta-analysis. J Psychosom Res 2019;126:109823
26. Sterne JAC, Savovic J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019;366:l4898
28. Grob CS, Danforth AL, Chopra GS, Hagerty M, McKay CR, Halberstadt AL, et al. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Arch Gen Psychiatry 2011;68:71–78.
30. Agin-Liebes GI, Malone T, Yalch MM, Mennenga SE, Ponté KL, Guss J, et al. Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer. J Psychopharmacol 2020;34:155–166.
35. Nic Dhonnchadha BA, Hascoet M, Jolliet P, Bourin M. Evidence for a 5-HT2A receptor mode of action in the anxiolytic-like properties of DOI in mice. Behav Brain Res 2003;147:175–184.
36. Ripoll N, Hascoet M, Bourin M. Implication of 5-HT2A subtype receptors in DOI activity in the four-plates test-retest paradigm in mice. Behav Brain Res 2006;166:131–139.
37. Ripoll N, Nic Dhonnchadha BA, Sebille V, Bourin M, Hascoët M. The four-plates test-retest paradigm to discriminate anxiolytic effects. Psychopharmacology (Berl) 2005;180:73–83.
40. Straube T, Schmidt S, Weiss T, Mentzel HJ, Miltner WH. Dynamic activation of the anterior cingulate cortex during anticipatory anxiety. Neuroimage 2009;44:975–981.
42. Nichols DE, Johnson MW, Nichols CD. Psychedelics as medicines: an emerging new paradigm. Clin Pharmacol Ther 2017;101:209–219.
44. Aronson JK. Psilocybin. In: Aronson JK, editor. Meyler’s Side Effects of Drugs (Sixteenth Edition). Oxford: Elsevier, 2016, p. 1048–1051.